29th Apr 2022 14:33
Celadon Pharmaceuticals Plc - London-based manufacturer and supplier of cannabinoid-based medicines formerly known as Summerway Capital PLC - Posts widened loss in the 16 months ended December 31. Loss grows to GBP720,369 from GBP174,511 in the year ended August 31, 2020. The firm had unaudited cash of GBP12.1 million as of April 22. Cash and cash equivalents fall to GBP4.5 million from GBP5.5 million.
Current stock price: 115.55 pence, untraded
12-month change: down 42%
By Tom Budszus; [email protected]
Copyright 2022 Alliance News Limited. All Rights Reserved.
Related Shares:
Celadon Pharmaceuticals